Skip to content
The Nexus
DossierENTITY

GLP-1 receptor agonist

Coverage of GLP-1 receptor agonist in the Nexus archive.

Earliest in view: Jul 13 · 21:00 UTCMost recent: Jul 31 · 21:19 UTC
Co-mentioned in this coverage
Veteranstopic2U.S. Department of Veterans Affairsorganization1semaglutidetopic1alcohol use disordertopic1Heather Woolery-Lloydperson1Nutrafolorganization1hair losstopic1weight losstopic1Act+Acreorganization1Helen Reaveyperson1basal insulin therapytopic1type 2 diabetestopic1
Recent coverage
  • HEALTHJul 31 · 21:19 UTCKTLA 5
    Veterans to test GLP-1 drugs as alcohol addiction treatment

    The U.S. Department of Veterans Affairs is launching a clinical trial to evaluate semaglutide, a GLP-1 receptor agonist, as a treatment for alcohol use disorder in veterans. Over 600 veterans will participate in the nationwide study.

  • HEALTHJul 22 · 20:14 UTCWTOP DC
    Why Do GLP-1 Weight Loss Medications Cause Hair Loss — and Is It Reversible?

    GLP-1 weight loss medications may cause hair loss due to rapid weight loss and reduced nutrient intake, not the medication itself. Hair loss is often reversible with proper nutrition and care, as the hair growth cycle responds to internal physiological changes.

  • HEALTHJul 13 · 21:00 UTCMEDPAGE TODAY
    Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes

    A study found that adding a GLP-1 receptor agonist did not reduce the likelihood of veterans with type 2 diabetes discontinuing basal insulin therapy compared to other glucose-lowering agents. The findings suggest GLP-1s may not serve as an effective insulin off-ramp for this population.